China SXT Pharmaceuticals, Inc. (SXTC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $1.86. It has a SharesGrow Score of 26/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Valuation: SXTC trades at a trailing Price-to-Earnings (P/E) of -2.1 (S&P 500 average ~25).
Financials: revenue is $2M, -12.1%/yr average growth. Net income is $3M (loss), growing at +12.6%/yr. Net profit margin is -189.8% (negative). Gross margin is 21.1% (-27 pp trend).
Balance sheet: total debt is $983,877 against $15M equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 3.54 (strong liquidity). Debt-to-assets is 4.5%. Total assets: $22M.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 48/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 14/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).
